Skip to Content

T. Rowe Price Corporate Income I TICCX

Medalist Rating as of | See T. Rowe Price Investment Hub
  • NAV / 1-Day Return 7.80  /  +0.27 %
  • Total Assets 533.5 Mil
  • Adj. Expense Ratio
    0.410%
  • Expense Ratio 0.410%
  • Distribution Fee Level Below Average
  • Share Class Type Institutional
  • Category Corporate Bond
  • Credit Quality / Interest Rate Sensitivity Medium/Moderate
  • Min. Initial Investment 500,000
  • Status Open
  • TTM Yield 4.50%
  • Effective Duration 6.62 years

USD | NAV as of Apr 23, 2024 | 1-Day Return as of Apr 23, 2024, 10:17 PM GMT+0

Morningstar’s Analysis TICCX

Will TICCX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A sound investment process and strong management team underpin T. Rowe Price Corporate Income I's Morningstar Medalist Rating of Gold.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a cost advantage over competitors, priced within the second-cheapest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings TICCX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 8.9
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

CVS Health Corp 5.05%

1.23 6.7 Mil
Corporate

Santander UK Group Holdings PLC 1.532%

1.14 6.2 Mil
Corporate

Citigroup Inc. 3.98%

1.06 5.7 Mil
Corporate

Revvity Inc 1.9%

0.96 5.2 Mil
Corporate

T-Mobile USA, Inc. 5.75%

0.92 5.0 Mil
Corporate

Citigroup Inc. 2.572%

0.87 4.7 Mil
Corporate

Morgan Stanley 4.431%

0.86 4.7 Mil
Corporate

Meta Platforms Inc 4.45%

0.86 4.7 Mil
Corporate

Danske Bank A/S 4.298%

0.84 4.6 Mil
Corporate

Sonic Cap Llc 3.845%

0.81 4.4 Mil
Securitized